Navigation Links
CEL-SCI Corporation Announces 2007 Financial Results
Date:1/14/2008

VIENNA, Va., Jan. 14 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (Amex: CVM) reports financial results for the fiscal year ending September 30, 2007.

CEL-SCI reports a net operating loss for fiscal year 2007 of $9,352,209 versus a net operating loss of $5,349,196 in fiscal year 2006. The loss per share for fiscal year 2007 was unchanged at $(0.10) compared to fiscal year 2006.

The cash from operating activities used during the year was about $4,890,100. CEL-SCI's assets during the year grew from $9.6 million in fiscal year 2006 to $20.7 million in fiscal year 2007.

Geert Kersten, Chief Executive Officer said, "CEL-SCI had a very successful year in that it received FDA go-ahead for a Phase III clinical trial with its cancer drug Multikine, raised substantial amounts of money and began building a dedicated manufacturing facility for Multikine. We are looking forward to taking over the completed facility in 2008 and starting the global Phase III trial."

About CEL-SCI's Phase III Cancer Drug Multikine:

In Phase II clinical trials Multikine was shown to be safe and well- tolerated, and to improve the patients' overall survival by 33% at a median of three and a half years following surgery. The U.S. Food and Drug Administration (FDA) gave the go-ahead for a Phase III clinical trial with Multikine in January 2007 and granted orphan drug status to Multikine in the neoadjuvant therapy of squamous cell carcinoma (cancer) of the head and neck in May 2007.

Multikine, a patented defined mixture of naturally derived cytokines, is the first immunotherapeutic agent in a new class of drugs called "Immune SIMULATORS". Immune SIMULATORS simulate the way our natural immune system acts in defending us against cancer.
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
2. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
3. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
4. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
5. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
6. CEL-SCI Corporation Releases Letter to Shareholders
7. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
8. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
9. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
10. Immunosyn Corporation Releases SF-1019 Study Results
11. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Pixcelldata, the innovative Irish developer of ... major new deal with Dutch based eX-Path, global providers ... Marius Nap . The announcement was ... Pathology which is taking placing between August 30th and ... where Pixcelldata will demonstrate its innovative solution. ...
(Date:8/29/2014)... ANDOVER, Mass. , Aug. ...  (NYSE: PHG ... at the  European Society of ... company is highlighting the full range of its cardiology solutions ... the care continuum from prevention and ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com ... report is available in its catalogue: ... Compliance Services Industry (U.S.): Analytics, Extensive ... to 2021, NAIC 541380 ... Testing Laboratories, Safety and Compliance ...
Breaking Medicine Technology:Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6
... Conn., Aug. 23 MedClean Technologies, Inc. (OTC Bulletin Board: ... technology for the treatment and disposal of ... media, today announced financial results for the 2010 second quarter ... of the recent highlights include : ...
... Reaffirms its 2010 Guidance -- XI,AN, China, Aug. 23 /PRNewswire-Asia-FirstCall/ -- ... ... ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
Cached Medicine Technology:MedClean Technologies Announces Second Quarter Results 2MedClean Technologies Announces Second Quarter Results 3MedClean Technologies Announces Second Quarter Results 4MedClean Technologies Announces Second Quarter Results 5Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 2Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 3Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 4Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 5Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 6Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 7Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 8Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 9
(Date:8/29/2014)... Honey Gifts, premium Vancouver adult toys ... be selling purse-sized adult toys and erotic products. These ... can be carried in a woman’s purse with complete ... at Honey Gifts is also leak-free and will not ... batteries are common characteristics of Honey Gifts’ portable toys ...
(Date:8/29/2014)... Ore. (PRWEB) August 29, 2014 University ... of health sciences professionals, announced that Daniel Redwood, DC, ... was named “Educator of the Year,” by the Missouri ... banquet on August 21. , Patrick Montgomery, DC, president ... appointed member of the Missouri House Task Force for ...
(Date:8/29/2014)... August 29, 2014 The ... revenue growth over the five years to 2014 ... consumers had less disposable income and, consequently, reduced ... visited restaurants less frequently. As a result, demand ... hindering revenue growth. “After 2010, levels of household ...
(Date:8/29/2014)... Aug. 29, 2014 (HealthDay News) -- The West African Ebola ... Health Organization announcing an estimated 500 new cases this week ... of the new cases arose in Liberia, the U.N. health ... rose sharply, the Associated Press reported. "There ... control," according to the WHO report. "The situation is worsening ...
(Date:8/29/2014)... CA (PRWEB) August 29, 2014 Evolutions ... Santa Barbara in the Santa Barbara News-Press Readers’ Choice ... won the Readers’ Choice poll as Best Medical Spa. ... 2014 reads the following about Evolutions Medical Spa recognition: ... but it is recognized as a top-notch, cutting-edge medical ...
Breaking Medicine News(10 mins):Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:University of Western States Director of Human Nutrition and Functional Medicine Daniel Redwood, DC, named Missouri Educator of the Year by MSCA 2Health News:Fruit and Vegetable Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Fruit and Vegetable Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 2Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 3Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3
... March 22 (HealthDay News) -- New research suggests that middle-age ... less likely to suffer from heart disease over their lives. ... high-fiber diets to lower rates of high blood pressure, obesity ... to the conclusion after studying the results of a 2003-2008 ...
... to be female, suffer from a neurological or mental disorder, ... in the March issue of the Journal of the ... alcohol abuse by the perpetrator plays a substantial role and ... professor of environmental and occupational health sciences at the University ...
... To help continue its internationally recognized work in Lewy ... awarded Mayo Clinic a $1 million gift, pledged over four ... Alzheimer,s and Parkinson,s diseases , is the second ... VIDEO ALERT: Additional audio and video resources, including ...
... 22 (HealthDay News) -- A low-cost screening test detected potentially ... children and teens in a pilot study. The findings ... for heart conditions that can lead to sudden cardiac arrest ... said in a hospital news release. Researchers found that ...
... (March 22, 2011) When physical therapy and drugs fail to ... fusion surgery as a last resort, but two new studies ... involved, artificial disc replacement may give better long-term results at ... 49 percent lower, and four years out from surgery, artificial ...
... Salamon HealthDay Reporter , MONDAY, March 21 ... presumably have more opportunities for tanning -- are nearly ... cancer melanoma as their poorest counterparts, a new study ... incidence, ultraviolet (UV) light exposure and socioeconomic status, scientists ...
Cached Medicine News:Health News:Elderly victims of abuse often use alcohol or drugs, study says 2Health News:Gift will allow Mayo researchers to explore cause of dementia in the elderly 2Health News:Gift will allow Mayo researchers to explore cause of dementia in the elderly 3Health News:Screening Seems to Catch Dangerous Heart Condition in Kids 2Health News:For back, neck pain, artificial disc replacement has cost, outcome advantages over fusion surgery 2Health News:For back, neck pain, artificial disc replacement has cost, outcome advantages over fusion surgery 3Health News:Richer White Women More Prone to Melanoma, Study Finds 2Health News:Richer White Women More Prone to Melanoma, Study Finds 3
Designed to minimize emblolic debris in SVGs and carotids...
... therapy extends the ability of interventional ... coronary artery disease, and provides non-interventional ... in the treatment of patients who ... EECP therapy provides a noninvasive, atraumatic ...
... The dual lumen petite titanium ... mm catheter (each lumen) and ... oval lumen catheters offer larger ... catheter strength. Dual lumen offset-tip ...
... The dual lumen M.R.I. model ... 1.2 mm inner diameter catheters ... catheters offer larger lumen equivalency ... ,Dual lumen offset-tip catheters are ...
Medicine Products: